A few hours after boarding Marine One for a flight to Walter Reed Hospital in Bethesda, Maryland, on Friday night, President Trump tweeted that he thinks things are "going well" as he received a new treatment for COVID-19.
While the White House remained fairly tight-lipped about the details of Trump's case, saying only that he had "mild symptoms," The New York Times reports those symptoms — including coughing, congestion, and a low-grade fever — worsened throughout the day. It's unclear if the worsening symptoms directly led to a change in the president's treatment, but he did begin receiving the antiviral drug remdesivir Friday evening, his physician Sean Conley said. The Food and Drug Administration granted an emergency use authorization for Remdesivir, which is developed by Gilead, earlier this year after it improved outcomes for hospitalized coronavirus patients.
Earlier Friday, Trump was treated with an experimental antibody cocktail developed by Regeneron. Conley said Trump is "doing very well" and has not needed any supplemental oxygen. Read more at The New York Times and The Hill.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.